Development of a novel prognostic score for 1-year survival in immunotherapy-treated patients with unresectable HCC: the ALIVE-IO score

BackgroundThere is a lack in reliable and widely used prognostic scores to predict survival in patients with hepatocellular carcinoma (HCC) receiving immunotherapy. The aim of our study was to develop a prognostic score that could predict 1-year OS in patients with unresectable HCC receiving immunot...

詳細記述

書誌詳細

出版年:	Frontiers in Immunology
主要な著者:	Spyridon Pantzios, Orestis Sidiropoulos, Antonia Syriha, Nikolaos Ptohis, Ioannis Skouras, Evgenia Mainta, Dimitris P. Korkolis, Nikolaos Machairas, Georgios C. Sotiropoulos, Ioannis Elefsiniotis
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2025-08-01
主題:	HCC immunotherapy prognostic score ALIVE-IO score ALBI up-to-7 criteria
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1648248/full